Cargando…

Alpelisib for breast cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218394/
https://www.ncbi.nlm.nih.gov/pubmed/35755985
http://dx.doi.org/10.18773/austprescr.2022.029
_version_ 1784731878267289600
collection PubMed
description
format Online
Article
Text
id pubmed-9218394
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-92183942022-06-23 Alpelisib for breast cancer Aust Prescr New Drugs NPS MedicineWise 2022-04-29 2022-06 /pmc/articles/PMC9218394/ /pubmed/35755985 http://dx.doi.org/10.18773/austprescr.2022.029 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Alpelisib for breast cancer
title Alpelisib for breast cancer
title_full Alpelisib for breast cancer
title_fullStr Alpelisib for breast cancer
title_full_unstemmed Alpelisib for breast cancer
title_short Alpelisib for breast cancer
title_sort alpelisib for breast cancer
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218394/
https://www.ncbi.nlm.nih.gov/pubmed/35755985
http://dx.doi.org/10.18773/austprescr.2022.029